Litcius/Paper detail

Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes

Stephen Harrow, David A. Palma, Robert Olson, Stewart Gaede, Alexander V. Louie, Cornelis J.A. Haasbeek, Liam Mulroy, Michael Lock, George Rodrigues, Brian Yaremko, Devin Schellenberg, Belal Ahmad, Sashendra Senthi, Anand Swaminath, Neil Kopek, Mitchell Liu, Roel Schlijper, Glenn Bauman, Joanna Laba, Xiaotao Qu, Andrew Warner, Suresh Senan

2022International Journal of Radiation Oncology*Biology*Physics202 citationsDOIOpen Access PDF

Topics & Concepts

SABR volatility modelMedicineHazard ratioClinical endpointRandomized controlled trialConfidence intervalRadiation therapyProstate cancerInternal medicineOncologySurgeryCancerEconomicsStochastic volatilityFinancial economicsVolatility (finance)Hepatocellular Carcinoma Treatment and PrognosisManagement of metastatic bone diseaseBrain Metastases and Treatment
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes | Litcius